Correlation Between Brookfield Office and Pfizer

Can any of the company-specific risk be diversified away by investing in both Brookfield Office and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brookfield Office and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Brookfield Office Properties and Pfizer Inc CDR, you can compare the effects of market volatilities on Brookfield Office and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brookfield Office with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brookfield Office and Pfizer.

Diversification Opportunities for Brookfield Office and Pfizer

-0.66

Correlation Coefficient

Brookfield Office  Pfizer

Excellent diversification

The 3 months correlation between Brookfield and Pfizer is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Brookfield Office Properties and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Brookfield Office is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brookfield Office Properties are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Brookfield Office i.e., Brookfield Office and Pfizer go up and down completely randomly.

Pair Corralation between Brookfield Office and Pfizer

Assuming the 90 days trading horizon Brookfield Office Properties is expected to under-perform the Pfizer. But the preferred stock apears to be less risky and, when comparing its historical volatility, Brookfield Office Properties is 1.25 times less risky than Pfizer. The preferred stock trades about -0.05 of its potential returns per unit of risk. The Pfizer Inc CDR is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,216  in Pfizer Inc CDR on September 24, 2024 and sell it today you would earn a total of  6.00  from holding Pfizer Inc CDR or generate 0.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Brookfield Office Properties  vs.  Pfizer Inc CDR

Brookfield Office

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Brookfield Office Properties are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Brookfield Office may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pfizer Inc CDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Brookfield Office and Pfizer

The main advantage of trading using opposite Brookfield Office and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brookfield Office position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind Brookfield Office Properties and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.